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Objectives: Exocrine pancreatic failure has been reported to affect 73−90% of
cystic ﬁbrosis (CF) patients. Fecal elastase test (FE) is the most widespread tool
for assessing exocrine pancreatic function, but has limitations regarding sensitivity
and speciﬁcity. Secretin stimulated short endoscopic tests (EST) are currently being
validated as a test for exocrine pancreatic function in other pancreatic diseases. We
aimed to validate EST as a direct pancreatic function test in CF-patients, and to
assess the levels of HCO3- and pancreatic enzymes in duodenal juice obtained by
EST.
Methods: 33 cystic ﬁbrosis patients and 24 healthy controls (HC) were examined.
30 minutes after secretin stimulation, the tip of an endoscope was placed in
the descending duodenum and duodenal juice was aspirated during a 15-minute
sampling-period. Duodenal juice was analyzed for HCO3- and lipase-, amylase-,
chymotrypsin- and elastase-concentrations. All subjects had stool analyzed for FE.
Using the FE cutoff of 200 mg/g patients were classiﬁed as exocrine pancreatic
sufﬁcient (CFS, n = 18) or insufﬁcient (CFI n = 15).
Conclusion: Pancreatic exocrine insufﬁcient CF patients could be differentiated
from exocrine sufﬁcient patients and healthy controls using this new test. EST
supplied detailed information on duodenal peak concentration of HCO3- and
pancreatic enzymes. Both bicarbonate- and pancreatic enzyme-concentrations were
signiﬁcantly reduced in CFI group compared to CFS and HC groups (p< 0.001).
238 Faecal calprotectin is increased in CF patients with pancreatic
insufﬁciency
A. Fjellsson1, E. Karlge-Nilsson2, B.A. Andersson3, A. Lindblad4, M. Gilljam1.
1Sahlgrenska Academy, Go¨teborg University, Respiratory Medicine, Go¨teborg,
Sweden; 2Sahlgrenska Academy, Go¨teborg University, Pediadrics, Go¨teborg,
Sweden; 3Sahlgrenska Academy, Go¨teborg University, Clinical Immunology,
Go¨teborg, Sweden; 4Sahlgrenska Academy, Go¨teborg University, Pediatrics,
Go¨teborg, Sweden
Objectives: Intestinal inﬂammation may contribute to abdominal symptoms and
nutritional problems in CF. We wanted to ﬁnd out how faecal calprotectin, a marker
of intestinal inﬂammation, correlated with abdominal symptoms, nutritional status
and dosage of pancreatic enzymes.
Methods: Patients attending the Gothenburg CF centre were asked to leave a stool
sample for analysis at the yearly assessment. Enzyme dosage and abdominal symp-
toms were recorded. Adult patients were also asked to complete the CF-QUEST
gastrointestinal (GI) module (Tullis et al). There were 73 patients [66% males,
42% <18 years, 15% pancreatic sufﬁcient (PS)] included. The mean value of faecal
calprotectin was 186±404mg/kg (median 70, range 0–2400), with values above
the upper normal limit of 50mg/kg in 44 (60%) patients. PS patients had lower
calprotectin levels (only 1/11 >50mg/kg) compared to pancreatic insufﬁcient (PI)
patients while there was no difference for gender or age group. There was no
correlation between calprotectin and CF-QUEST GI symptom score. Calprotectin
>1000mg/kg was detected in four patients; one newly diagnosed infant, one adult
with signiﬁcant GERD, one 10-year-old boy and one adult − both with recurrent
abdominal pain and discomfort.
Conclusion: Increased faecal calprotectin is common in pancreatic insufﬁcient CF
and is detected also in patients with minor symptoms. Further research regarding
the clinical use of this test is needed.
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Objectives: The majority of cystic ﬁbrosis (CF) patients develop pancreatic damage
and exocrine pancreatic insufﬁciency. Characteristic morphological features include
marked acinar atrophy, ﬁbrosis and fatty replacement. Parenchymal and functional
aspects in ultrasound (US) imaging of the CF pancreas related to exocrine pancreatic
function is however, scarcely reported.
Methods: CF patients were examined by secretin stimulated US and a detailed
pancreatic US. We also examined 2 groups of healthy controls (HC1 and HC2)
with the respective methods. Secretin US: Measurements of diameter of the Wirsung
duct and the descending duodenum were done before and during 15 minutes after
secretin stimulation. The US examination was followed by an endoscopic short test
(EST) for exocrine pancreatic function. Pancreatic US: Ductal and parenchymal
criteria according to Rosemont and echo level measurements of liver and pancreas
were registered. CF patients and HC1 also had stool analyzed for fecal elastase (FE).
CF patients were classiﬁed as exocrine pancreatic insufﬁcient (CFI) or sufﬁcient
(CFS) according to EST and FE.
Conclusion: Lipomatosis was the main ﬁnding in CF patients with higher grade
and frequency in CFI (p< 0.001). Typical signs of chronic pancreatitis according
to Rosemont were not present in CF. Ultrasonographic measures of Wirsung duct
dilatation and ﬂuid ﬁlling of the duodenum after secretin stimulation discriminated
CFI from CFS. Ultrasonography adds useful information of pancreatic function
in CF.
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Objectives: Gastric emptying (GE) can be normal, decreased or increased in
children with cystic ﬁbrosis (CF) according to the literature. We showed in
a previous study that 47.4% of children with CF with gastro-intestinal and/or
respiratory symptoms suggestive for gastro-oesophageal reﬂux had delayed GE. We
studied now GE in children with CF without chronic gastrointestinal symptoms.
Methods: Nineteen children with CF (12 boys and 7 girls, mean age 9 years
and range 5−13 years) without chronic gastrointestinal symptoms were studied. A
13C-octanoic acid breath test was performed to measure GE of solids (pancake)
using Non Dispersive Infrared Spectrometry (Wagner Analysen Technik, Bremen,
Germany). Gastric half emptying time (t1/2) was calculated and compared with
t1/2 obtained in healthy subjects (Hauser, unpublished data). GE was considered
as delayed if t1/2 was above the 95 th percentile. Two of the 19 children (10.5%,
1 boy and 1 girl) had delayed GE.
Conclusions: Delayed GE is present in only a minority of children with CF without
chronic gastrointestinal symptoms.
